Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
癌予防用ハイブリッド細胞ワクチンの調製および投与
Document Type and Number:
Japanese Patent JP2006509830
Kind Code:
A
Abstract:
The present invention relates to methods for preventing cancer and for treating and preventing development and progression of pre-cancerous lesions by administering a therapeutically effective dose of fusion cells formed by fusion of dendritic cells and precancerous non-dendritic cells, either alone or in combination with a cytokine or other molecule which stimulates or induces a cytotoxic T cell response and/or a humoral immune response.

More Like This:
WO/2020/194195T CELL RECEPTORS AND METHODS OF USE THEREOF
WO/2023/234407ORAL VACCINE COMPOSITION
WO/2011/097573METHODS AND COMPOSITIONS FOR CANCER IMMUNOTHERAPY USING FLAGELLIN-TUMOR ASSOCIATED ANTIGEN FUSION PROTEIN EXPRESSING TUMOR CELLS
Inventors:
Noriya Ohno
Application Number:
JP2004563716A
Publication Date:
March 23, 2006
Filing Date:
December 16, 2003
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Noriya Ohno
International Classes:
A61K39/00; A61K35/12; A61K35/14; A61K38/00; A61P35/00; A61P37/04; C12N5/02; C12N15/09
Domestic Patent References:
JP2002501377A2002-01-15
JP2001526622A2001-12-18
Foreign References:
WO2001059073A22001-08-16
Attorney, Agent or Firm:
Yusuke Hiraki
Ishii Teiji
Satoshi Fujita



 
Previous Patent: フェノール、アセトン、α−メチルスチレン及び酸化プロピレンのコプロ...

Next Patent: フルオロオレフィンの製造方法